See more : Laser Photonics Corporation (LASE) Income Statement Analysis – Financial Results
Complete financial analysis of China Botanic Pharmaceutical Inc. (CBPI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Botanic Pharmaceutical Inc., a leading company in the Shell Companies industry within the Financial Services sector.
- AtlasClear Holdings, Inc. (ATCH) Income Statement Analysis – Financial Results
- Malayan Banking Berhad (MLYNF) Income Statement Analysis – Financial Results
- AFT Pharmaceuticals Limited (AFP.AX) Income Statement Analysis – Financial Results
- Kingboard Holdings Limited (KBDCF) Income Statement Analysis – Financial Results
- Spearmint Resources Inc. (SPMTF) Income Statement Analysis – Financial Results
China Botanic Pharmaceutical Inc. (CBPI)
Industry: Shell Companies
Sector: Financial Services
About China Botanic Pharmaceutical Inc.
China Botanic Pharmaceutical Inc. does not have significant operations. It intends to explore and identify business opportunities within the United States, including a potential acquisition of an operating entity through a reverse merger, asset purchase, or similar transaction. The company was formerly known as Renhuang Pharmaceuticals, Inc. and changed its name to China Botanic Pharmaceutical Inc. in November 2010. China Botanic Pharmaceutical Inc. was incorporated in 1988 and is based in New York, New York.
| Metric | 2021 | 2020 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 72.71M | 55.18M | 43.41M | 36.16M | 28.04M | 0.00 | 50.29M | 63.06M | 59.06M | 26.62M | 10.99M | 4.69M | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 29.53M | 25.77M | 20.31M | 15.98M | 13.69M | 0.00 | 37.05M | 48.49M | 39.90M | 16.69M | 7.53M | 3.41M | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 43.18M | 29.42M | 23.10M | 20.18M | 14.35M | 0.00 | 13.24M | 14.57M | 19.17M | 9.93M | 3.46M | 1.28M | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 59.39% | 53.31% | 53.21% | 55.81% | 51.16% | 0.00% | 26.33% | 23.11% | 32.45% | 37.30% | 31.51% | 27.24% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 3.59M | 3.04M | 2.53M | 2.12M | 282.01K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 325.09K | 0.00 | 0.00 | 0.00 | 4.05M | 3.61M | 2.12M | 2.62M | 2.55M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 6.02M | 4.97M | 3.65M | 3.32M | 1.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 325.09K | 0.00 | 0.00 | 0.00 | 10.07M | 8.58M | 5.77M | 5.94M | 4.08M | 0.00 | 15.90M | 15.06M | 17.71M | 10.08M | 6.72M | 3.06M | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | -109.90M | 0.00 | 0.00 | 0.00 | 256.86K | 424.27K | 878.71K | 740.18K | 617.05K | 371.46K | 156.61K | 3.14M | 0.00 | 29.43K | 1.78K |
| Operating Expenses | 325.09K | 0.00 | 0.00 | -109.90M | 13.66M | 11.62M | 8.30M | 8.32M | 4.79M | 878.71K | 16.64M | 15.68M | 18.08M | 10.24M | 9.86M | 3.06M | 29.43K | 1.78K |
| Cost & Expenses | 325.09K | 0.00 | 0.00 | -109.90M | 43.19M | 37.39M | 28.61M | 24.30M | 18.48M | 878.71K | 53.69M | 64.17M | 57.98M | 26.93M | 17.39M | 6.47M | 29.43K | 1.78K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 126.94K | 74.52K | 42.72K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 236.56K | 206.30K | 0.00 | 0.00 | 953.49K | 799.22K | 356.44K | 339.26K | 293.64K | 0.00 | 257.81K | 90.19K | 286.74K | 224.74K | 707.04K | 132.44K | 0.00 | 0.00 |
| EBITDA | -325.09K | 0.00 | 0.00 | -109.90M | 30.60M | 18.67M | 15.20M | 12.32M | 9.89M | 878.71K | -3.20M | -1.03M | 1.19M | -217.97K | -5.87M | -1.66M | -29.43K | -1.78K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 42.08% | 33.83% | 35.02% | 34.07% | 35.27% | 0.00% | -6.35% | -1.64% | 2.01% | -0.82% | -53.37% | -35.50% | 0.00% | 0.00% |
| Operating Income | -325.09K | 0.00 | 0.00 | -109.90M | 29.65M | 17.87M | 14.85M | 11.98M | 9.60M | 878.71K | -3.45M | -1.12M | 902.39K | -442.71K | -6.57M | -1.80M | -29.43K | -1.78K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 40.77% | 32.38% | 34.20% | 33.13% | 34.22% | 0.00% | -6.87% | -1.78% | 1.53% | -1.66% | -59.81% | -38.32% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 117.69K | 35.64K | 0.00 | -618.13K | -656.56K | -405.35K | 902.83M | -3.12M | -14.95K | 0.00 | 0.00 |
| Income Before Tax | -325.09K | 0.00 | 0.00 | -109.90M | 29.65M | 17.87M | 14.85M | 11.98M | 9.60M | 0.00 | -4.07M | -1.78M | 497.05K | -556.46K | -9.69M | -1.81M | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 40.77% | 32.38% | 34.20% | 33.13% | 34.22% | 0.00% | -8.10% | -2.82% | 0.84% | -2.09% | -88.15% | -38.64% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 3.73M | 0.00 | 0.00 | 0.00 | 0.00 | -878.71K | -618.13K | -656.56K | -405.35K | -113.74K | -3.12M | -14.95K | 29.43K | 1.78K |
| Net Income | -325.09K | 0.00 | 0.00 | -109.90M | 25.92M | 17.87M | 14.85M | 11.98M | 9.60M | 878.71K | -3.45M | -1.12M | 902.39K | -442.71K | -6.57M | -1.80M | -29.43K | -1.78K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 35.65% | 32.38% | 34.20% | 33.13% | 34.22% | 0.00% | -6.87% | -1.78% | 1.53% | -1.66% | -59.81% | -38.32% | 0.00% | 0.00% |
| EPS | -0.01 | 0.00 | 0.00 | -2.95 | 0.70 | 0.48 | 0.41 | 0.34 | 0.27 | 106.37 | -21.23 | -6.93 | 9.76 | -7.33 | -0.18 | -0.13 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | -2.95 | 0.69 | 0.44 | 0.41 | 0.34 | 0.27 | 106.37 | -21.23 | -6.93 | 4.42 | -7.33 | -0.18 | -0.13 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 37.24M | 37.24M | 37.24M | 37.24M | 37.24M | 37.24M | 36.09M | 35.10M | 35.04M | 8.26K | 162.67K | 162.06K | 92.50K | 60.40K | 36.25M | 13.69M | 37.24M | 37.24M |
| Weighted Avg Shares Out (Dil) | 37.24M | 37.24M | 37.68M | 37.24M | 37.68M | 40.17M | 36.09M | 35.10M | 35.04M | 8.26K | 162.67K | 162.06K | 204.21K | 60.40K | 36.25M | 13.69M | 37.24M | 37.24M |
Source: https://incomestatements.info
Category: Stock Reports